Is the promise of randomized control trials ("evidence-based medicine") overstated? Louis R. Caplan Invited Commentary Pages: 1 - 8
Angioplasty and stenting for severe stenosis of the extracranial portion of the internal carotid artery Harold P. Adams Jr. Clinical Trials Report Pages: 15 - 17
Utility of noninvasive studies in the evaluation of patients with carotid artery disease Dean C. C. JohnstonLarry B. Goldstein OriginalPaper Pages: 25 - 30
Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke Eugene D. KaplanRalph L. Sacco OriginalPaper Pages: 31 - 37
Hemorrhagic transformation following ischemic stroke: Significance, causes, and relationship to therapy and treatment Paul A. Lapchak OriginalPaper Pages: 38 - 43
Treatment of arteriovenous malformations of the brain Jodi L. SmithBhuwan Garg OriginalPaper Pages: 44 - 49
Aminoglycoside treatment for muscular dystrophy is scientifically rational, but is it clinically effective? Michio Hirano Clinical Trials Report Pages: 53 - 54
Amyotrophic lateral sclerosis: Objective upper motor neuron markers Petra KaufmannHiroshi Mitsumoto OriginalPaper Pages: 55 - 60
Periodic paralysis: Understanding channelopathies Frank Lehmann-HornKarin Jurkat-RottReinhardt RĂ¼del OriginalPaper Pages: 61 - 69
The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy Cornelius F. BoerkoelHiroshi TakashimaJames R. Lupski OriginalPaper Pages: 70 - 77
Congenital myasthenic syndromes: Genetic defects of the neuromuscular junction Kinji OhnoAndrew G. Engel OriginalPaper Pages: 78 - 88